Home › Funds › RIVERBRIDGE PARTNERS LLC › GKOS
RIVERBRIDGE PARTNERS LLC position in GKOS
GLAUKOS CORP · Health Care
RIVERBRIDGE PARTNERS LLC reported holding 223,445 shares of GKOS (GLAUKOS CORP) in its Q3 2026 13F filing — a position valued at US$36.7M, representing 1.08% of its reported portfolio and ranking #29 among its reported holdings. RIVERBRIDGE PARTNERS LLC has disclosed GKOS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How RIVERBRIDGE PARTNERS LLC's GKOS position evolved
RIVERBRIDGE PARTNERS LLC first disclosed a stake in GKOS in Q3 2023 at 558,487 shares (US$42.0M). The position peaked in Q3 2024 at 476,682 shares, worth US$62.1M. Across 13 filings, RIVERBRIDGE PARTNERS LLC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 223,445 shares valued at US$36.7M — a reduction of -58,644 shares quarter over quarter.. Notable position changes include a 42% increase in Q2 2025 (shares fell 21% over the following quarter), a 41% increase in Q3 2025 (shares rose 38% over the following quarter), a 35% trim in Q2 2026 (shares rose 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 558.49K | $42.03M | New |
| Q4 2023 | 548.14K | $43.57M | Reduce |
| Q1 2024 | 534.51K | $50.40M | Reduce |
| Q2 2024 | 493.07K | $58.36M | Reduce |
| Q3 2024 | 476.68K | $62.10M | Reduce |
| Q4 2024 | 312.93K | $46.92M | Reduce |
| Q1 2025 | 285.46K | $28.10M | Reduce |
| Q2 2025 | 403.97K | $41.73M | Add |
| Q3 2025 | 569.64K | $46.45M | Add |
| Q4 2025 | 535.17K | $60.43M | Reduce |
| Q1 2026 | 433.23K | $46.64M | Reduce |
| Q2 2026 | 282.09K | $39.42M | Reduce |
| Q3 2026 | 223.44K | $36.69M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GKOS and 13F data
GKOS (GLAUKOS CORP) is a Health Care company. 45 other funds we track also report a position in GKOS — the largest reported positions include BRAIDWELL LP (US$82.7M), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$62.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GKOS
- BRAIDWELL LP 591.93K sh · $82.73M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 446.55K sh · $62.41M · Q2 2026
More on RIVERBRIDGE PARTNERS LLC
FAQ
How long has RIVERBRIDGE PARTNERS LLC held GKOS?
RIVERBRIDGE PARTNERS LLC has disclosed GKOS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RIVERBRIDGE PARTNERS LLC's current position in GKOS?
As of Q3 2026, RIVERBRIDGE PARTNERS LLC holds 223.44K shares of GKOS (GLAUKOS CORP), valued at $36.69M, representing 1.08% of its reported portfolio and ranking #29.
Has RIVERBRIDGE PARTNERS LLC been buying or selling GKOS?
In the latest 13F filing (Q3 2026), RIVERBRIDGE PARTNERS LLC reduced its position in GKOS. The position peaked in Q3 2024 at 476.68K shares.
Which other funds hold GKOS?
Other major institutional holders of GKOS include BRAIDWELL LP, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.